nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A prospective study of prevalence and characterization of headache following mild traumatic brain injury
|
Lucas, Sylvia |
|
2014 |
34 |
2 |
p. 93-102 |
artikel |
2 |
BMS-927711 for the acute treatment of migraine
|
Bigal, Marcelo E |
|
2014 |
34 |
2 |
p. 90-92 |
artikel |
3 |
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
|
Marcus, Ronald |
|
2014 |
34 |
2 |
p. 114-125 |
artikel |
4 |
Central scotoma and ‘muddled thinking’ as migraine aura
|
Daroff, Robert B |
|
2014 |
34 |
2 |
p. 158-158 |
artikel |
5 |
Comment on “Central scotoma and ‘muddled thinking’ as migraine aura” by Daroff
|
Petrusic, I |
|
2014 |
34 |
2 |
p. 159-159 |
artikel |
6 |
Consistency of eletriptan in treating migraine: Results of a randomized, within-patient multiple-dose study
|
Almas, Mary |
|
2014 |
34 |
2 |
p. 126-135 |
artikel |
7 |
Definitions need to be consistent with the facts. Reply to Parisi et al.
|
Cianchetti, Carlo |
|
2014 |
34 |
2 |
p. 154-155 |
artikel |
8 |
Epidemiology and classification of post-traumatic headache: What do we know and how do we move forward? Comment on Lucas et al., “Prevalence and characterization of headache following mild TBI”
|
Scher, Ann I |
|
2014 |
34 |
2 |
p. 83-85 |
artikel |
9 |
Glutamate and migraine: From Ikeda to the 21st century
|
Ramadan, Nabih M |
|
2014 |
34 |
2 |
p. 86-89 |
artikel |
10 |
Headache as a presenting feature in patients with serotonin syndrome: A case series
|
Prakash, Sanjay |
|
2014 |
34 |
2 |
p. 148-153 |
artikel |
11 |
Ictal epileptic headache: Moving forward. Reply to Cianchetti et al.
|
Parisi, Pasquale |
|
2014 |
34 |
2 |
p. 156-157 |
artikel |
12 |
Nitric oxide synthase, calcitonin gene-related peptide and NK-1 receptor mechanisms are involved in GTN-induced neuronal activation
|
Ramachandran, Roshni |
|
2014 |
34 |
2 |
p. 136-147 |
artikel |
13 |
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks
|
Gomez-Mancilla, Baltazar |
|
2014 |
34 |
2 |
p. 103-113 |
artikel |